The clinical features of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-
HLH) vary significantly, from mild to severe, at the time of the treatment decision. There are …

Abstract Background Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis
(EBV‐HLH) leads to an aggressive and often fatal course without appropriate treatment …

Secondary hemophagocytic lymphohistiocytosis (sHLH) is a reactive, proliferative disorder
of the immune system resulting in lymphohistiocytic proliferation, hemophagocytosis, and …

Abstract Background Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis
(EBV‐HLH), also known as EBV‐associated hemophagocytic syndrome, develops mostly in …

The familial form of hemophagocytic lymphohistiocytosis (HLH) is a lethal disorder. Although
the prognosis for Epstein-Barr virus–associated HLH (EBV-HLH) remains uncertain …

BACKGROUND AND OBJECTIVES: Although immunochemotherapy has been reported to
be an effective initial treatment for patients with Epstein-Barr virus-associated …

ABSTRACT Objectives: Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
is the most common type of infection-associated HLH. Previous studies were focused on …

Background Despite several advances in the treatment of Epstein–Barr virus (EBV) in recent
years, patients with Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis …

Epstein–Barr virus (EBV) is the major triggering factor producing hemophagocytic syndrome
or hemophagocytic lymphohistiocytosis (HLH). In this review, diagnostic problems, clinical …

Background The clinical characteristics of Epstein-Barr virus-associated hemophagocytic
lymphohistiocytosis (EBV-HLH) are largely unreported in the pediatric patients in mainland …